What is Euroapi?
Euroapi, established in 2021 and headquartered in France, is a prominent pharmaceutical manufacturer focused on active pharmaceutical ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) services. The company boasts a portfolio of approximately 200 products and supports innovative molecule development. With six manufacturing sites strategically located across Europe, including facilities in France, Italy, Germany, Hungary, and the United Kingdom, Euroapi serves a global customer base in over 80 countries. Its operations are characterized by a blend of scientific expertise and industrial capability, ensuring the delivery of high-quality pharmaceutical solutions that adhere to stringent international standards. Euroapi is committed to developing sustainable active ingredient solutions for its healthcare partners worldwide and is publicly traded on Euronext Paris.
How much funding has Euroapi raised?
Euroapi has raised a total of $474M across 1 funding round:
Debt
$474M
Debt (2024): $474M with participation from Sanofi
Key Investors in Euroapi
Sanofi
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
What's next for Euroapi?
The recent major strategic investment in Euroapi, following a substantial overall capital infusion, suggests a trajectory geared towards scaling operations and potentially expanding its CDMO capabilities or API production capacity. This significant backing positions Euroapi to further solidify its market presence and pursue innovation in pharmaceutical ingredient development. The company's focus on sustainable solutions and its broad European manufacturing footprint are likely to be key drivers in its future growth, enabling it to meet the increasing global demand for high-quality APIs and specialized pharmaceutical manufacturing services.
See full Euroapi company page
